Skip to main content
. 2020 Apr 20;98(5):751–760. doi: 10.1007/s00109-020-01907-w

Fig. 4.

Fig. 4

Signaling lipid mediators (endocannabinoids) in control group and ocular MMP patients. The intensity represents the relative quantitation of each metabolite